FDA accelerated approval | Neurology Associates

top of page

M-F 8 a.m. - 4 p.m. | 480 800 4890 | Insurance Info

Search

Lecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With Caution

Lecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With Caution

Lecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With Caution

Neurology Associates Neuroscience Center looks at the side effects of lecanemab, the newly FDA-approved drug for Alzheimer's.

Jan 18, 20232 min read

Alzheimer’s Drug Lecanemab Could Get FDA Accelerated Approval This Week

Alzheimer’s Drug Lecanemab Could Get FDA Accelerated Approval This Week

Alzheimer’s Drug Lecanemab Could Get FDA Accelerated Approval This Week

A Neurology Associates Neuroscience Center blog about the pending FDA accelerated approval of experimental Alzheimer's drug lecanemab.

Jan 3, 20232 min read

bottom of page